位置:首页 > 蛋白库 > DEF4_MESMA
DEF4_MESMA
ID   DEF4_MESMA              Reviewed;          62 AA.
AC   P0DQT9;
DT   25-MAY-2022, integrated into UniProtKB/Swiss-Prot.
DT   25-MAY-2022, sequence version 1.
DT   03-AUG-2022, entry version 2.
DE   RecName: Full=Defensin BmKDfsin4 {ECO:0000303|PubMed:24129506};
DE   AltName: Full=4 kDa defensin {ECO:0000250|UniProtKB:P41965};
DE   Flags: Precursor;
OS   Mesobuthus martensii (Manchurian scorpion) (Buthus martensii).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Chelicerata; Arachnida;
OC   Scorpiones; Buthida; Buthoidea; Buthidae; Mesobuthus.
OX   NCBI_TaxID=34649;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   TISSUE=Muscle;
RX   PubMed=24129506; DOI=10.1038/ncomms3602;
RA   Cao Z., Yu Y., Wu Y., Hao P., Di Z., He Y., Chen Z., Yang W., Shen Z.,
RA   He X., Sheng J., Xu X., Pan B., Feng J., Yang X., Hong W., Zhao W., Li Z.,
RA   Huang K., Li T., Kong Y., Liu H., Jiang D., Zhang B., Hu J., Hu Y.,
RA   Wang B., Dai J., Yuan B., Feng Y., Huang W., Xing X., Zhao G., Li X.,
RA   Li Y., Li W.;
RT   "The genome of Mesobuthus martensii reveals a unique adaptation model of
RT   arthropods.";
RL   Nat. Commun. 4:2602-2602(2013).
RN   [2]
RP   FUNCTION, 3D-STRUCTURE MODELING, RECOMBINANT EXPRESSION, AND MUTAGENESIS OF
RP   LYS-37; ARG-43; ARG-44; ARG-45 AND ARG-61.
RX   PubMed=26817841; DOI=10.1074/jbc.m115.680611;
RA   Meng L., Xie Z., Zhang Q., Li Y., Yang F., Chen Z., Li W., Cao Z., Wu Y.;
RT   "Scorpion potassium channel-blocking defensin highlights a functional link
RT   with neurotoxin.";
RL   J. Biol. Chem. 291:7097-7106(2016).
RN   [3]
RP   FUNCTION, AND RECOMBINANT EXPRESSION.
RX   PubMed=27128943; DOI=10.3390/toxins8050124;
RA   Zeng Z., Zhang Q., Hong W., Xie Y., Liu Y., Li W., Wu Y., Cao Z.;
RT   "A scorpion defensin BmKDfsin4 inhibits hepatitis B virus replication in
RT   vitro.";
RL   Toxins 8:0-0(2016).
CC   -!- FUNCTION: Dual-function peptide with antimicrobial and potassium
CC       channel-blocking activities (PubMed:26817841). Shows inhibitory
CC       activity against Gram-positive bacteria such as S.aureus, B.subtilis,
CC       and M.luteus as well as methicillin-resistant S.aureus (MIC=0.1-20 uM)
CC       (PubMed:26817841). Does not act on bacteria by disrupting membranes
CC       (PubMed:26817841). Also moderately inhibits Kv1.1/KCNA1 (25.2%
CC       inhibition at 1 uM), Kv1.2/KCNA2 (30.5% inhibition at 1 uM), and
CC       Kv1.3/KCNA3 potassium channels (IC(50)=510.2 nM, 61% inhibition at 1
CC       uM) (PubMed:26817841). Inhibits potassium channels by interacting with
CC       the pore region (PubMed:26817841). Does not show hemolytic activity
CC       (PubMed:27128943). In vitro, dose-dependently decreases the production
CC       of Hepatitis B virus (HBV) DNA and HBV viral proteins in both culture
CC       medium and cell lysate (PubMed:27128943). {ECO:0000269|PubMed:26817841,
CC       ECO:0000269|PubMed:27128943}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000305|PubMed:24129506}.
CC   -!- DOMAIN: Has the structural arrangement of an alpha-helix connected to a
CC       beta-sheet by disulfide bonds (CSalpha/beta).
CC       {ECO:0000305|PubMed:26817841}.
CC   -!- MISCELLANEOUS: Has no inhibitory activity against Gram-negative
CC       bacteria (PubMed:26817841). Shows very weak inhibition of the potassium
CC       currents mediated by the Kv11.1/KCNH2/ERG1 (11.6%), KCa3.1/KCNN4/IK/SK4
CC       (3.9%), KCa2.3/KCNN3/SK3 (7%), Kv7/KCNQ (5.9%), when tested at 1 uM
CC       (PubMed:26817841). {ECO:0000269|PubMed:26817841}.
CC   -!- SIMILARITY: Belongs to the invertebrate defensin family. Type 2
CC       subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0015459; F:potassium channel regulator activity; IEA:UniProtKB-KW.
DR   GO; GO:0090729; F:toxin activity; IEA:UniProtKB-KW.
DR   GO; GO:0042742; P:defense response to bacterium; IEA:UniProtKB-KW.
DR   GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
DR   Gene3D; 3.30.30.10; -; 1.
DR   InterPro; IPR001542; Defensin_invertebrate/fungal.
DR   InterPro; IPR036574; Scorpion_toxin-like_sf.
DR   Pfam; PF01097; Defensin_2; 1.
DR   SUPFAM; SSF57095; SSF57095; 1.
DR   PROSITE; PS51378; INVERT_DEFENSINS; 1.
PE   1: Evidence at protein level;
KW   Antibiotic; Antimicrobial;
KW   Calcium-activated potassium channel impairing toxin; Defensin;
KW   Disulfide bond; Immunity; Innate immunity; Ion channel impairing toxin;
KW   Neurotoxin; Potassium channel impairing toxin; Secreted; Signal; Toxin;
KW   Voltage-gated potassium channel impairing toxin.
FT   SIGNAL          1..24
FT                   /evidence="ECO:0000255"
FT   CHAIN           25..62
FT                   /note="Defensin BmKDfsin4"
FT                   /evidence="ECO:0000305|PubMed:24129506"
FT                   /id="PRO_0000455528"
FT   SITE            37
FT                   /note="Key residue in interaction with Kv1.3/KCNA3"
FT                   /evidence="ECO:0000269|PubMed:26817841"
FT   SITE            43
FT                   /note="Key residue in interaction with Kv1.3/KCNA3"
FT                   /evidence="ECO:0000269|PubMed:26817841"
FT   DISULFID        28..49
FT                   /evidence="ECO:0000250|UniProtKB:A0A384E0Y8"
FT   DISULFID        35..57
FT                   /evidence="ECO:0000250|UniProtKB:A0A384E0Y8"
FT   DISULFID        39..59
FT                   /evidence="ECO:0000250|UniProtKB:A0A384E0Y8"
FT   MUTAGEN         37
FT                   /note="K->A: Important decrease in ability to block
FT                   Kv1.3/KCNA3 potassium channel."
FT                   /evidence="ECO:0000269|PubMed:26817841"
FT   MUTAGEN         43
FT                   /note="R->A: Important decrease in ability to block
FT                   Kv1.3/KCNA3 potassium channel."
FT                   /evidence="ECO:0000269|PubMed:26817841"
FT   MUTAGEN         44
FT                   /note="R->A: Moderate decrease in abmility to block
FT                   Kv1.3/KCNA3 potassium channel."
FT                   /evidence="ECO:0000269|PubMed:26817841"
FT   MUTAGEN         45
FT                   /note="R->A: Moderate decrease in ability to block
FT                   Kv1.3/KCNA3 potassium channel."
FT                   /evidence="ECO:0000269|PubMed:26817841"
FT   MUTAGEN         61
FT                   /note="R->A: Moderate decrease in ability to block
FT                   Kv1.3/KCNA3 potassium channel."
FT                   /evidence="ECO:0000269|PubMed:26817841"
SQ   SEQUENCE   62 AA;  7074 MW;  6FFEC316F4DFD529 CRC64;
     MKTIVLLFVL ALVFCTLEMG IVEAGFGCPF NQGQCHKHCQ SIRRRGGYCD GFLKQRCVCY
     RK
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024